Ana Rita Álvaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ana Rita Álvaro has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Cláudia Cavadas
Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
23 shared publications - Joana Rosmaninho-Salgado
CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
8 shared publications - António Francisco Ambrósio
Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal
6 shared publications - Catarina Carvalhas-Almeida
CNC - UC- Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
6 shared publications Cláudia Cavadas
CNC-UC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
6 shared publications- Luís Pereira de Almeida
Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal
6 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Clock gene signature predicts insomnia and links to sleep/circadian parameters
Chronic Insomnia is a prevalent sleep disorder that remains difficult to diagnose due to subjective symptoms and heterogeneous presentations. The most severe form, insomnia with short sleep duration (ISSD), is defined by a total sleep time of less than six hours on polysomnography. However, objective assessments are rarely recommended in diagnostic guidelines, highlighting the need for alternative biomarkers. Disruptions in the circadian clock system may contribute to chronic insomnia, though the extent of these effects remains unclear. In this study, we investigate sleep and circadian rhythm-related alterations in chronic insomnia and its subtypes, ISSD and insomnia with normal sleep duration (INSD), by assessing plasma cortisol, wrist and axillary temperature, and clock gene expression in peripheral blood mononuclear cells (PBMCs). Additionally, we use machine learning to identify the most relevant clock genes for detecting insomnia and classifying its subtypes. Chronic insomnia patients exhibited reduced body temperature rhythms, elevated cortisol levels during wake before sleep, and significant alterations in clock gene expression, including in BMAL1, PER1-2, REV-ERBα, and REV-ERBβ, compared to controls. Most alterations were more significant in the ISSD group. Moreover, associations between clock gene expression, sleep-related parameters and Insomnia Severity Index (ISI) scores were identified. Using machine learning, we identified three genes as sensitive biomarkers distinguishing chronic insomnia from controls and differentiating between ISSD and INSD subtypes. Our findings suggest that circadian markers and machine learning could improve understanding of chronic insomnia and aid biomarker discovery for diagnosis.
- 1 July 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessClock gene signature predicts insomnia and links to sleep/circadian parameters
Chronic Insomnia is a prevalent sleep disorder that remains difficult to diagnose due to subjective symptoms and heterogeneous presentations. The most severe form, insomnia with short sleep duration (ISSD), is defined by a total sleep time of less than six hours on polysomnography. However, objective assessments are rarely recommended in diagnostic guidelines, highlighting the need for alternative biomarkers. Disruptions in the circadian clock system may contribute to chronic insomnia, though the extent of these effects remains unclear. In this study, we investigate sleep and circadian rhythm-related alterations in chronic insomnia and its subtypes, ISSD and insomnia with normal sleep duration (INSD), by assessing plasma cortisol, wrist and axillary temperature, and clock gene expression in peripheral blood mononuclear cells (PBMCs). Additionally, we use machine learning to identify the most relevant clock genes for detecting insomnia and classifying its subtypes. Chronic insomnia patients exhibited reduced body temperature rhythms, elevated cortisol levels during wake before sleep, and significant alterations in clock gene expression, including in BMAL1, PER1-2, REV-ERBα, and REV-ERBβ, compared to controls. Most alterations were more significant in the ISSD group. Moreover, associations between clock gene expression, sleep-related parameters and Insomnia Severity Index (ISI) scores were identified. Using machine learning, we identified three genes as sensitive biomarkers distinguishing chronic insomnia from controls and differentiating between ISSD and INSD subtypes. Our findings suggest that circadian markers and machine learning could improve understanding of chronic insomnia and aid biomarker discovery for diagnosis.
- Open Access
- 4 December 2025
- Published by SAGE Publications in Journal of Biological Rhythms
- Vol. 41 (1) , 122-138
Regulation of Metabolic Rhythms by Glial Clocks
Rhythmicity is a central feature of behavioral and physiological processes, including sleep, immune responses, and metabolism. Research on brain control of these processes has largely focused on neurons, with less known about the role of clock genes in glial cells. In this study, we addressed the function of glial clocks by targeting the expression of key clock genes in glia of Drosophila melanogaster. Loss of the period (per ) gene in glia increases sleep following aseptic injury and loss of either per or timeless ( tim) significantly reduces locomotor activity in light:dark cycles and in constant dark, but other than this, the major effect of clock gene loss in glia is on metabolic function. We demonstrate that disruption of either tim or per in glia affects glycogen stores and reduces metabolic rate. Disruption of either tim or per in glia also affects rhythms of feeding and overall food consumption. Notably, these effects of clock disruption are mediated by distinct glial subtypes, especially cortex glia. We propose that the major role of glial clocks is in the control of energy homeostasis and metabolic rhythms, which likely also accounts for effects on locomotor activity. These findings link metabolism and behavior via circadian regulation in glia.
- 4 December 2025
- Published by SAGE Publications in Journal of Biological Rhythms
- Vol. 41 (1) , 122-138
Open AccessRegulation of Metabolic Rhythms by Glial Clocks
Rhythmicity is a central feature of behavioral and physiological processes, including sleep, immune responses, and metabolism. Research on brain control of these processes has largely focused on neurons, with less known about the role of clock genes in glial cells. In this study, we addressed the function of glial clocks by targeting the expression of key clock genes in glia of Drosophila melanogaster. Loss of the period (per ) gene in glia increases sleep following aseptic injury and loss of either per or timeless ( tim) significantly reduces locomotor activity in light:dark cycles and in constant dark, but other than this, the major effect of clock gene loss in glia is on metabolic function. We demonstrate that disruption of either tim or per in glia affects glycogen stores and reduces metabolic rate. Disruption of either tim or per in glia also affects rhythms of feeding and overall food consumption. Notably, these effects of clock disruption are mediated by distinct glial subtypes, especially cortex glia. We propose that the major role of glial clocks is in the control of energy homeostasis and metabolic rhythms, which likely also accounts for effects on locomotor activity. These findings link metabolism and behavior via circadian regulation in glia.
- Open Access
- 1 October 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (178) , 250073
Systematic review of changes in extracellular vesicles associated with obstructive sleep apnoea: implications for diagnosis and treatment
Obstructive sleep apnoea (OSA) is a major public health concern, strongly linked to cardiovascular disease and cancer. Extracellular vesicles (EVs) have emerged as key mediators in intercellular communication, oxidative stress and inflammation, carrying molecules that can influence OSA pathophysiology. However, their role in OSA pathophysiology remains underexplored. This systematic review consolidates current research on EVs in OSA, focusing on their cargo, surface proteins and impact on oxidative stress, inflammation, cancer progression and cardiovascular dysfunction. Registered in the International Prospective Register of Systematic Reviews (ID CRD 42024537136), it explores the intricate links between OSA and EVs to uncover disease mechanisms and identify potential biomarkers. The search was conducted in PubMed/Medline and Web of Science databases to identify studies exploring OSA and EVs in clinical studies, animal studies and in vitro studies. Among the 600 unique studies screened, 27 met the inclusion criteria. These studies demonstrated that OSA-derived EVs influence key biological processes, such as endothelial dysfunction, inflammation and tumour cell proliferation. Transcriptomic and proteomic analyses revealed dysregulation of specific microRNAs and proteins in EVs from OSA patients in comparison with controls. Notably, EVs studies in clinical, animal and in vitro settings were shown to enhance cancer cell migration and endothelial dysfunction, underscoring their potential as biomarkers for OSA-related comorbidities. EVs hold great promise as minimally invasive, cost-effective biomarkers for understanding OSA mechanisms, diagnosis and prognosis. However, stricter characterisation and comprehensive profiling of their dynamics and cargo are essential to standardise methodologies and clarify their role in the disease.
- 1 October 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (178) , 250073
Open AccessSystematic review of changes in extracellular vesicles associated with obstructive sleep apnoea: implications for diagnosis and treatment
Obstructive sleep apnoea (OSA) is a major public health concern, strongly linked to cardiovascular disease and cancer. Extracellular vesicles (EVs) have emerged as key mediators in intercellular communication, oxidative stress and inflammation, carrying molecules that can influence OSA pathophysiology. However, their role in OSA pathophysiology remains underexplored. This systematic review consolidates current research on EVs in OSA, focusing on their cargo, surface proteins and impact on oxidative stress, inflammation, cancer progression and cardiovascular dysfunction. Registered in the International Prospective Register of Systematic Reviews (ID CRD 42024537136), it explores the intricate links between OSA and EVs to uncover disease mechanisms and identify potential biomarkers. The search was conducted in PubMed/Medline and Web of Science databases to identify studies exploring OSA and EVs in clinical studies, animal studies and in vitro studies. Among the 600 unique studies screened, 27 met the inclusion criteria. These studies demonstrated that OSA-derived EVs influence key biological processes, such as endothelial dysfunction, inflammation and tumour cell proliferation. Transcriptomic and proteomic analyses revealed dysregulation of specific microRNAs and proteins in EVs from OSA patients in comparison with controls. Notably, EVs studies in clinical, animal and in vitro settings were shown to enhance cancer cell migration and endothelial dysfunction, underscoring their potential as biomarkers for OSA-related comorbidities. EVs hold great promise as minimally invasive, cost-effective biomarkers for understanding OSA mechanisms, diagnosis and prognosis. However, stricter characterisation and comprehensive profiling of their dynamics and cargo are essential to standardise methodologies and clarify their role in the disease.
- Open Access
- 22 July 2025
- Published by Oxford University Press (OUP) in Brain
- Vol. 148 (11) , 4127-4142
Circadian rhythms are disrupted in patients and preclinical models of Machado-Joseph disease
Machado-Joseph disease (MJD) is caused by an abnormal CAG repeat expansion in the ATXN3 gene, leading to the expression of a mutant ataxin-3 (mutATXN3) protein. Patients with MJD exhibit a wide range of clinical symptoms, including motor incoordination. Emerging evidence highlights circadian rhythm disruptions as early indicators and potential risk factors for the progression of neurodegenerative conditions. Circadian rhythms are regulated by internal clocks, with the suprachiasmatic nucleus (SCN) acting as the master pacemaker to synchronize timing across the body’s behavioural and physiological functions. While sleep disturbances have been observed in MJD, the role of clock regulation in its pathophysiology remains largely unexplored in spinocerebellar ataxias. This study aimed to investigate circadian rhythms, characterize associated disruptions and uncover the mechanisms underlying clock dysregulation in patients and preclinical models of MJD. Circadian activity in MJD patients was assessed over 2 weeks using actigraphy, while in a YAC-MJD transgenic mouse model, circadian rhythms were examined through: (i) wheel-running experiments; (ii) telemetry-based monitoring of core body temperature; (iii) immunohistochemical analysis of the neuropeptides arginine vasopressin (AVP) and vasoactive intestinal polypeptide (VIP) in the SCN and paraventricular nucleus (PVN); and (iv) quantitative real-time PCR evaluation of clock gene expression in the cerebellum. The impact of mutATXN3 on clock mechanisms was further investigated using Bmal1/Per2-luciferase reporters. MJD patients exhibited a progressive decline in robustness of behavioural rhythms, demonstrated by negative correlations between the circadian function index, rest-activity fragmentation and sleep efficiency with MJD clinical scales. YAC-MJD mice exhibited reduced activity levels and increased behavioural fragmentation, and they required three additional days to re-entrain after a jet lag protocol compared to controls. Disrupted core body temperature rhythms were observed, including a phase advance and elevated temperature (∼1°C) at the onset of the active period. Furthermore, transgenic mice showed reduced levels of VIP and AVP in the SCN and PVN and decreased clock gene expression in the cerebellum. Lastly, we found new mechanistic evidence that wild-type ATXN3 activates the promoters of Bmal1 and Per2, whereas mutATXN3 loses the capacity to drive Per2 upon polyglutamine expansion. Overall, our findings indicate that central clock dysfunction in MJD is associated with impaired clock gene expression and disruptions in activity and temperature rhythms. This study provides the first robust evidence of circadian rhythm dysregulation and underlying mechanisms in MJD, paving the way for identifying new biomarkers and developing novel circadian-based interventions to tackle MJD and possibly other spinocerebellar ataxias.
- 22 July 2025
- Published by Oxford University Press (OUP) in Brain
- Vol. 148 (11) , 4127-4142
Open AccessCircadian rhythms are disrupted in patients and preclinical models of Machado-Joseph disease
Machado-Joseph disease (MJD) is caused by an abnormal CAG repeat expansion in the ATXN3 gene, leading to the expression of a mutant ataxin-3 (mutATXN3) protein. Patients with MJD exhibit a wide range of clinical symptoms, including motor incoordination. Emerging evidence highlights circadian rhythm disruptions as early indicators and potential risk factors for the progression of neurodegenerative conditions. Circadian rhythms are regulated by internal clocks, with the suprachiasmatic nucleus (SCN) acting as the master pacemaker to synchronize timing across the body’s behavioural and physiological functions. While sleep disturbances have been observed in MJD, the role of clock regulation in its pathophysiology remains largely unexplored in spinocerebellar ataxias. This study aimed to investigate circadian rhythms, characterize associated disruptions and uncover the mechanisms underlying clock dysregulation in patients and preclinical models of MJD. Circadian activity in MJD patients was assessed over 2 weeks using actigraphy, while in a YAC-MJD transgenic mouse model, circadian rhythms were examined through: (i) wheel-running experiments; (ii) telemetry-based monitoring of core body temperature; (iii) immunohistochemical analysis of the neuropeptides arginine vasopressin (AVP) and vasoactive intestinal polypeptide (VIP) in the SCN and paraventricular nucleus (PVN); and (iv) quantitative real-time PCR evaluation of clock gene expression in the cerebellum. The impact of mutATXN3 on clock mechanisms was further investigated using Bmal1/Per2-luciferase reporters. MJD patients exhibited a progressive decline in robustness of behavioural rhythms, demonstrated by negative correlations between the circadian function index, rest-activity fragmentation and sleep efficiency with MJD clinical scales. YAC-MJD mice exhibited reduced activity levels and increased behavioural fragmentation, and they required three additional days to re-entrain after a jet lag protocol compared to controls. Disrupted core body temperature rhythms were observed, including a phase advance and elevated temperature (∼1°C) at the onset of the active period. Furthermore, transgenic mice showed reduced levels of VIP and AVP in the SCN and PVN and decreased clock gene expression in the cerebellum. Lastly, we found new mechanistic evidence that wild-type ATXN3 activates the promoters of Bmal1 and Per2, whereas mutATXN3 loses the capacity to drive Per2 upon polyglutamine expansion. Overall, our findings indicate that central clock dysfunction in MJD is associated with impaired clock gene expression and disruptions in activity and temperature rhythms. This study provides the first robust evidence of circadian rhythm dysregulation and underlying mechanisms in MJD, paving the way for identifying new biomarkers and developing novel circadian-based interventions to tackle MJD and possibly other spinocerebellar ataxias.
- Open Access
- 25 June 2025
- Published by Springer Nature in Research Square
Clock gene signature predicts Insomnia and links to sleep/circadian parameters
Chronic Insomnia is a prevalent sleep disorder that remains difficult to diagnose due to subjective symptoms and heterogeneous presentations. The most severe form, insomnia with short sleep duration (ISSD), is defined by a total sleep time of less than six hours on polysomnography. However, objective assessments are rarely recommended in diagnostic guidelines, highlighting the need for alternative biomarkers. Disruptions in the circadian clock system may contribute to chronic insomnia, though the extent of these effects remains unclear. In this study, we investigate sleep and circadian rhythm-related alterations in chronic insomnia and its subtypes, ISSD and insomnia with normal sleep duration (INSD), by assessing plasma cortisol, wrist and axillary temperature, and clock gene expression in peripheral blood mononuclear cells (PBMCs). Additionally, we use machine learning to identify the most relevant clock genes for detecting insomnia and classifying its subtypes. Chronic insomnia patients exhibited reduced body temperature rhythms, elevated nighttime cortisol levels, and significant alterations in clock genes expression, including in BMAL1, PER1-2, REV-ERBα, and REV-ERBβ, compared to controls. Most alterations were more significant in the ISSD. Moreover, associations between clock gene expression, sleep-related parameters and insomnia severity index (ISI) scores were identified. Using machine learning, we identified three genes as sensitive biomarkers distinguishing chronic insomnia from controls and differentiating between ISSD and INSD subtypes. Our findings suggest that circadian markers and machine learning could improve understanding of chronic insomnia and aid biomarker discovery for diagnosis.
- 25 June 2025
- Published by Springer Nature in Research Square
Open AccessClock gene signature predicts Insomnia and links to sleep/circadian parameters
Chronic Insomnia is a prevalent sleep disorder that remains difficult to diagnose due to subjective symptoms and heterogeneous presentations. The most severe form, insomnia with short sleep duration (ISSD), is defined by a total sleep time of less than six hours on polysomnography. However, objective assessments are rarely recommended in diagnostic guidelines, highlighting the need for alternative biomarkers. Disruptions in the circadian clock system may contribute to chronic insomnia, though the extent of these effects remains unclear. In this study, we investigate sleep and circadian rhythm-related alterations in chronic insomnia and its subtypes, ISSD and insomnia with normal sleep duration (INSD), by assessing plasma cortisol, wrist and axillary temperature, and clock gene expression in peripheral blood mononuclear cells (PBMCs). Additionally, we use machine learning to identify the most relevant clock genes for detecting insomnia and classifying its subtypes. Chronic insomnia patients exhibited reduced body temperature rhythms, elevated nighttime cortisol levels, and significant alterations in clock genes expression, including in BMAL1, PER1-2, REV-ERBα, and REV-ERBβ, compared to controls. Most alterations were more significant in the ISSD. Moreover, associations between clock gene expression, sleep-related parameters and insomnia severity index (ISI) scores were identified. Using machine learning, we identified three genes as sensitive biomarkers distinguishing chronic insomnia from controls and differentiating between ISSD and INSD subtypes. Our findings suggest that circadian markers and machine learning could improve understanding of chronic insomnia and aid biomarker discovery for diagnosis.
- Open Access
- 23 June 2025
- Published by Frontiers Media SA in Frontiers for Young Minds
- Vol. 13
Fatal Familial Insomnia: A Puzzle of a Rare Disease in Need of More Research
Rare diseases are diseases that affect fewer than 1 in 2,000 people. Due to their rarity, it can be extremely challenging for doctors to diagnose these diseases in their patients—it often takes 6–8 years for some patients to get a diagnosis. Even though they are uncommon, rare diseases still have a significant impact on families and communities and need greater attention. Fatal familial insomnia (FFI) is a rare disease that affects the brain and gradually reduces a person’s ability to sleep. FFI gets worse over time and causes severe complications. There is currently no cure for FFI, so more research is crucial—not only for understanding FFI but also for unlocking potential treatments for other rare diseases. Rare disease research brings hope for a better future to those living with FFI and other rare conditions.
- 23 June 2025
- Published by Frontiers Media SA in Frontiers for Young Minds
- Vol. 13
Open AccessFatal Familial Insomnia: A Puzzle of a Rare Disease in Need of More Research
Rare diseases are diseases that affect fewer than 1 in 2,000 people. Due to their rarity, it can be extremely challenging for doctors to diagnose these diseases in their patients—it often takes 6–8 years for some patients to get a diagnosis. Even though they are uncommon, rare diseases still have a significant impact on families and communities and need greater attention. Fatal familial insomnia (FFI) is a rare disease that affects the brain and gradually reduces a person’s ability to sleep. FFI gets worse over time and causes severe complications. There is currently no cure for FFI, so more research is crucial—not only for understanding FFI but also for unlocking potential treatments for other rare diseases. Rare disease research brings hope for a better future to those living with FFI and other rare conditions.
- Open Access
- 19 March 2025
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 81, 102080
Sleep and male (In)Fertility: A comprehensive overview
- 19 March 2025
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 81, 102080
Open AccessSleep and male (In)Fertility: A comprehensive overview
- 1 February 2024
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 35 (6) , 505-517
Modeling hypothalamic pathophysiology in vitro for metabolic, circadian, and sleep disorders
- 1 February 2024
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 35 (6) , 505-517
Modeling hypothalamic pathophysiology in vitro for metabolic, circadian, and sleep disorders
- Open Access
- 17 February 2023
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 147, 105100
Understanding neuron-glia crosstalk and biological clocks in insomnia
- 17 February 2023
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 147, 105100
Open AccessUnderstanding neuron-glia crosstalk and biological clocks in insomnia
- Open Access
- 30 December 2022
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 35 (2) , 253-269
The impact of insomnia on frailty and the hallmarks of aging
Throughout the course of life, there are age-related changes in sleep. Despite these normal changes, there is a high percentage of older adults that report sleep dissatisfaction with a high pervasiveness of chronic insomnia, the most common sleep disorder worldwide, with its prevalence being expected to continuously increase due to the growing rates of aging and obesity. This can have different adverse health outcomes, especially by promoting both physical and cognitive decline, which ultimately may aggravate frailty in older adults. Moreover, age-related frailty and sleep dysfunction may have a common mechanism related to the hallmarks of cellular aging. Cellular aging was categorized into nine hallmarks, such as DNA damage, telomere attrition and epigenetic changes. In the context of geriatric and chronic insomnia research, this review aims at discussing the current evidence from both animal models and human cohorts addressing the link between chronic insomnia, the hallmarks of aging and their impact on frailty. Moreover, the most recent research about the putative effect of insomnia therapeutic approaches on hallmarks of aging will be also highlighted.
- 30 December 2022
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 35 (2) , 253-269
Open AccessThe impact of insomnia on frailty and the hallmarks of aging
Throughout the course of life, there are age-related changes in sleep. Despite these normal changes, there is a high percentage of older adults that report sleep dissatisfaction with a high pervasiveness of chronic insomnia, the most common sleep disorder worldwide, with its prevalence being expected to continuously increase due to the growing rates of aging and obesity. This can have different adverse health outcomes, especially by promoting both physical and cognitive decline, which ultimately may aggravate frailty in older adults. Moreover, age-related frailty and sleep dysfunction may have a common mechanism related to the hallmarks of cellular aging. Cellular aging was categorized into nine hallmarks, such as DNA damage, telomere attrition and epigenetic changes. In the context of geriatric and chronic insomnia research, this review aims at discussing the current evidence from both animal models and human cohorts addressing the link between chronic insomnia, the hallmarks of aging and their impact on frailty. Moreover, the most recent research about the putative effect of insomnia therapeutic approaches on hallmarks of aging will be also highlighted.